To DOAC or Not to DOAC for Left Ventricular Thrombi-What Is the Dose?-Reply

Austin A Robinson^{1

2}, Cory R Trankle³, Grayson Eubanks⁴

Affiliations

¹ Department of Medicine, University of Virginia Health System, Charlottesville.
² Division of Cardiology, Scripps Clinic, La Jolla, California.
³ VCU Pauley Heart Center, Virginia Commonwealth University, Richmond.
⁴ Department of Medicine, University of North Carolina, Chapel Hill.

Comment

Austin A Robinson et al. JAMA Cardiol. 2021.

. 2021 May 1;6(5):604.

doi: 10.1001/jamacardio.2020.6897.

Austin A Robinson^{1

2}, Cory R Trankle³, Grayson Eubanks⁴

¹ Department of Medicine, University of Virginia Health System, Charlottesville.
² Division of Cardiology, Scripps Clinic, La Jolla, California.
³ VCU Pauley Heart Center, Virginia Commonwealth University, Richmond.
⁴ Department of Medicine, University of North Carolina, Chapel Hill.

No abstract available

Comment on

Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi.
Robinson AA, Trankle CR, Eubanks G, Schumann C, Thompson P, Wallace RL, Gottiparthi S, Ruth B, Kramer CM, Salerno M, Bilchick KC, Deen C, Kontos MC, Dent J. Robinson AA, et al. JAMA Cardiol. 2020 Jun 1;5(6):685-692. doi: 10.1001/jamacardio.2020.0652. JAMA Cardiol. 2020. PMID: 32320043 Free PMC article.
To DOAC or Not to DOAC for Left Ventricular Thrombi-What Is the Dose?
Manmadhan A, Berger JS, Ahuja T. Manmadhan A, et al. JAMA Cardiol. 2021 May 1;6(5):603-604. doi: 10.1001/jamacardio.2020.6894. JAMA Cardiol. 2021. PMID: 33471023 No abstract available.